Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Questions ... correction

RE: Questions ... correction

posted on Apr 07, 2006 03:13AM

I should have said ``I guess it`s pretty likely that OUR CUT OF the Fujitsu settlement was at least $15MM.`` This is assuming that the company would not dip into their previous cash holding to cover a portion of the dividend. The actual licensing agreement would need to be around $30MM for this to be true.

My bad.

Best Regards

Share
New Message
Please login to post a reply